<br/>The ongoing evolution of catalytic methodologies has allowed for the realization of new bond-forming reactions that chemists could previously only imagine. These novel transformations represent creative solutions to the complex challenges encountered in the synthesis of Active Pharmaceutical Ingredients (APIs). This presentation will highlight several recent examples on the discovery and development of new catalytic reactions at Merck Process R&D. Implementation of these methodologies has enabled the team to innovate toward streamlined, cost-effective and sustainable processes for drug candidates, while simultaneously providing fundamental advancements in synthetic organic chemistry.<br/>

Innovation at Merck Process R&D via discovery and development of new catalytic reactions

2019 Spring National Meeting

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.